CA2018638C - Mise en banque de cellules endocrines de pancreas pour les transplantations - Google Patents
Mise en banque de cellules endocrines de pancreas pour les transplantations Download PDFInfo
- Publication number
- CA2018638C CA2018638C CA 2018638 CA2018638A CA2018638C CA 2018638 C CA2018638 C CA 2018638C CA 2018638 CA2018638 CA 2018638 CA 2018638 A CA2018638 A CA 2018638A CA 2018638 C CA2018638 C CA 2018638C
- Authority
- CA
- Canada
- Prior art keywords
- cells
- freezing
- pancreatic endocrine
- frozen
- transplantation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000002054 transplantation Methods 0.000 title claims abstract description 46
- 210000003890 endocrine cell Anatomy 0.000 title claims abstract description 34
- 230000009996 pancreatic endocrine effect Effects 0.000 title claims abstract description 34
- 210000004027 cell Anatomy 0.000 claims abstract description 91
- 238000007710 freezing Methods 0.000 claims abstract description 44
- 238000000034 method Methods 0.000 claims abstract description 44
- 238000010257 thawing Methods 0.000 claims abstract description 39
- 206010012601 diabetes mellitus Diseases 0.000 claims abstract description 37
- 230000008014 freezing Effects 0.000 claims abstract description 35
- 238000003860 storage Methods 0.000 claims abstract description 17
- 230000002528 anti-freeze Effects 0.000 claims abstract description 9
- 230000008569 process Effects 0.000 claims abstract description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 47
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 26
- 206010022498 insulinoma Diseases 0.000 claims description 17
- 208000021255 pancreatic insulinoma Diseases 0.000 claims description 17
- 238000001816 cooling Methods 0.000 claims description 16
- 229960001760 dimethyl sulfoxide Drugs 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 230000000735 allogeneic effect Effects 0.000 claims description 14
- 210000004153 islets of langerhan Anatomy 0.000 claims description 13
- 239000007788 liquid Substances 0.000 claims description 13
- 229910052757 nitrogen Inorganic materials 0.000 claims description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 4
- 210000004369 blood Anatomy 0.000 claims description 4
- 239000008280 blood Substances 0.000 claims description 4
- 239000008103 glucose Substances 0.000 claims description 4
- 238000004017 vitrification Methods 0.000 claims description 3
- 230000002776 aggregation Effects 0.000 claims description 2
- 238000004220 aggregation Methods 0.000 claims description 2
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims description 2
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical group [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 claims 1
- 241000700159 Rattus Species 0.000 description 24
- 238000005138 cryopreservation Methods 0.000 description 21
- 238000002360 preparation method Methods 0.000 description 10
- 230000003833 cell viability Effects 0.000 description 9
- 230000035899 viability Effects 0.000 description 8
- 230000009467 reduction Effects 0.000 description 7
- 230000004083 survival effect Effects 0.000 description 7
- 238000001727 in vivo Methods 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 239000001963 growth medium Substances 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 239000012981 Hank's balanced salt solution Substances 0.000 description 4
- 238000011316 allogeneic transplantation Methods 0.000 description 4
- 238000013459 approach Methods 0.000 description 4
- 239000002577 cryoprotective agent Substances 0.000 description 4
- 231100000433 cytotoxic Toxicity 0.000 description 4
- 230000001472 cytotoxic effect Effects 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 238000007913 intrathecal administration Methods 0.000 description 4
- 238000011835 investigation Methods 0.000 description 4
- ZSJLQEPLLKMAKR-UHFFFAOYSA-N Streptozotocin Natural products O=NN(C)C(=O)NC1C(O)OC(CO)C(O)C1O ZSJLQEPLLKMAKR-UHFFFAOYSA-N 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 210000004698 lymphocyte Anatomy 0.000 description 3
- 230000002035 prolonged effect Effects 0.000 description 3
- ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 description 3
- 229960001052 streptozocin Drugs 0.000 description 3
- 238000003211 trypan blue cell staining Methods 0.000 description 3
- 241000282693 Cercopithecidae Species 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 2
- 230000030833 cell death Effects 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 230000005847 immunogenicity Effects 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 238000010606 normalization Methods 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 238000010583 slow cooling Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 229920001917 Ficoll Polymers 0.000 description 1
- 238000012424 Freeze-thaw process Methods 0.000 description 1
- 206010062016 Immunosuppression Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 206010052779 Transplant rejections Diseases 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 230000000961 alloantigen Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000005056 cell body Anatomy 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 210000003703 cisterna magna Anatomy 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000006371 metabolic abnormality Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 210000004923 pancreatic tissue Anatomy 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 210000004988 splenocyte Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 210000002330 subarachnoid space Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 238000002689 xenotransplantation Methods 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA 2018638 CA2018638C (fr) | 1990-06-08 | 1990-06-08 | Mise en banque de cellules endocrines de pancreas pour les transplantations |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA 2018638 CA2018638C (fr) | 1990-06-08 | 1990-06-08 | Mise en banque de cellules endocrines de pancreas pour les transplantations |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2018638A1 CA2018638A1 (fr) | 1991-12-08 |
| CA2018638C true CA2018638C (fr) | 2002-10-01 |
Family
ID=4145176
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA 2018638 Expired - Fee Related CA2018638C (fr) | 1990-06-08 | 1990-06-08 | Mise en banque de cellules endocrines de pancreas pour les transplantations |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA2018638C (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102738995B1 (ko) * | 2017-09-11 | 2024-12-06 | 노보 노르디스크 에이/에스 | 시험관 내 줄기 세포로부터 유래된 nkx6.1 및 c-펩티드 공발현 세포의 농축 |
-
1990
- 1990-06-08 CA CA 2018638 patent/CA2018638C/fr not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2018638A1 (fr) | 1991-12-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5679565A (en) | Method of preserving pancreatic islets | |
| US5827741A (en) | Cryopreservation of human adult and fetal pancreatic cells and human platelets | |
| JPH11500421A (ja) | 生物学的材料の大量低温保存法及び低温保存され、そして封入された生物学的材料の使用法 | |
| Rajotte et al. | Pancreatic islet banking: The transplantation of frozen-thawed rat islets transported between centers | |
| US8609328B2 (en) | Method of separating pancreatic islet | |
| Rajotte et al. | Transplantation of cryopreserved and fresh rat islets and canine pancreatic fragments: comparison of cryopreservation protocols | |
| WO2002032225A2 (fr) | Procede de conservation par le froid de tissus ou d'organes autres que des vaisseaux sanguins, par vitrification | |
| AU2002211792A1 (en) | Method of cryopreservation of tissues or organs other than a blood vessel by vitrification | |
| WO2014008432A1 (fr) | Cryoconservation de cellules à l'intérieur d'un dispositif de macro-encapsulation | |
| van Suylichem et al. | Rat islet isograft function: effect of graft volume and transplantation site | |
| WO1998014058A1 (fr) | Cryoconservation de cellules pancreatiques de foetus et de personne adulte et de plaquettes humaines | |
| Bretzel et al. | Islet transplantation in experimental diabetes of the rat VII. Cryopreservation of rat and human islets. Preliminary results | |
| Rajotte | Islet cryopreservation protocols | |
| Rabkin et al. | Transcontinental shipping of pancreatic islets for autotransplantation after total pancreatectomy | |
| WARNOCK et al. | Survival of cryopreserved isolated adult human pancreatic islets of Langerhans | |
| EvANs et al. | Reversal of diabetes in dogs by transplantation of pure cryopreserved islets | |
| US20220354108A1 (en) | Preservation methods using trehalose with other cryoprotectants being absent from the cryopreservation protocol | |
| Tze et al. | Successful banking of pancreatic endocrine cells for transplantation | |
| CA2018638C (fr) | Mise en banque de cellules endocrines de pancreas pour les transplantations | |
| Rajab et al. | Comparison of the portal vein and kidney subcapsule as sites for primate islet autotransplantation | |
| Marchetti et al. | Cryogenic storage of isolated, purified porcine pancreatic islets | |
| Lakey et al. | Bulk cryopreservation of isolated islets of Langerhans | |
| Corominola et al. | Cryopreservation of pancreatic islets prior to transplantation: a comparison between UW solution and RPMI culture medium | |
| JP2003047464A (ja) | 動物細胞の保存方法 | |
| Warnock et al. | Effects of precryopreservation culture on survival of rat islets transplanted after slow cooling and rapid thawing |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |